Toshio Mochizuki

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 10

Top Venues

Clinical and experimental nephrology

Kidney360

Hepatology international

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Taro Akihisa, Hiroshi Kataoka, Shiho Makabe, Shun Manabe, Rie Yoshida, Yusuke Ushio, Masayo Sato, Ken Tsuchiya, Toshio Mochizuki, Kosaku Nitta
Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney disease. Clinical and experimental nephrology 26 (6) (2022)
Masayo Sato, Toshio Mochizuki, Kosaku Nitta
Persistent Isolated Hematuria in a Japanese Woman. Kidney360 2 (3) (2021)
Hiroshi Kataoka, Saki Watanabe, Masayo Sato, Shun Manabe, Shiho Makabe, Taro Akihisa, Yusuke Ushio, Naomi Iwasa, Rie Yoshida, Ken Tsuchiya, Kosaku Nitta, Toshio Mochizuki
Predicting liver cyst severity by mutations in patients with autosomal-dominant polycystic kidney disease. Hepatology international 15 (3) (2021)
Seiji Hashimoto, Tomochika Maoka, Tetsuya Kawata, Toshio Mochizuki, Takao Koike, Takashi Shigematsu
Roles of Insulin Receptor Substrates (IRS) in renal function and renal hemodynamics. PloS one 15 (12) (2020)
Masayo Sato, Hiroshi Kataoka, Yusuke Ushio, Shun Manabe, Saki Watanabe, Taro Akihisa, Shiho Makabe, Rie Yoshida, Naomi Iwasa, Michihiro Mitobe, Norio Hanafusa, Ken Tsuchiya, Kosaku Nitta, Toshio Mochizuki
High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study. Medicines (Basel, Switzerland) 7 (3) (2020)
Hiroshi Kataoka, Mamiko Ohara, Toshio Mochizuki, Kazuhiro Iwadoh, Yusuke Ushio, Keiko Kawachi, Kentaro Watanabe, Saki Watanabe, Taro Akihisa, Shiho Makabe, Shun Manabe, Masayo Sato, Naomi Iwasa, Rie Yoshida, Yukako Sawara, Norio Hanafusa, Ken Tsuchiya, Kosaku Nitta
Sex Differences in Time-Series Changes in Pseudo-R2 Values Regarding Hyperuricemia in Relation to the Kidney Prognosis. Journal of personalized medicine 10 (4) (2020)
Shun Manabe, Ayami Ino, Yoei Miyabe, Sekiko Taneda, Hiroshi Kataoka, Toshio Mochizuki, Kosaku Nitta
Everolimus-associated focal segmental glomerulosclerosis in a liver transplant recipient. Nephrology (Carlton, Vic.) 26 (4) (2020)
Saki Watanabe, Jun Ino, Takuya Fujimaru, Sekiko Taneda, Taro Akihisa, Shiho Makabe, Hiroshi Kataoka, Takayasu Mori, Eisei Sohara, Shinichi Uchida, Kosaku Nitta, Toshio Mochizuki
PKD1 mutation may epistatically ameliorate nephronophthisis progression in patients with NPHP1 deletion. Clinical case reports 7 (2) (2019)
Hiroshi Kataoka, Takahito Moriyama, Shun Manabe, Keiko Kawachi, Yusuke Ushio, Saki Watanabe, Taro Akihisa, Shiho Makabe, Masayo Sato, Naomi Iwasa, Yukako Sawara, Mamiko Ohara, Sekiko Taneda, Keiko Uchida, Kazuho Honda, Toshio Mochizuki, Ken Tsuchiya, Kosaku Nitta
Maximum Glomerular Diameter and Oxford MEST-C Score in IgA Nephropathy: The Significance of Time-Series Changes in Pseudo-R2 Values in Relation to Renal Outcomes. Journal of clinical medicine 8 (12) (2019)
Toshio Mochizuki, Atsuko Teraoka, Hiroyuki Akagawa, Shiho Makabe, Taro Akihisa, Masayo Sato, Hiroshi Kataoka, Michihiro Mitobe, Toru Furukawa, Ken Tsuchiya, Kosaku Nitta
Mutation analyses by next-generation sequencing and multiplex ligation-dependent probe amplification in Japanese autosomal dominant polycystic kidney disease patients. Clinical and experimental nephrology 23 (8) (2019)

Toshio Mochizuki.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Toshio Mochizuki